ICMR and Panacea Biotec initiate the first dengue vaccine Phase 3 Clinical Trial in India This landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll
Public dengue immunisation program launched in Philippines 1 million students from 6,000 public schools to begin dengue vaccinations this year The first public dengue immunisation…
Phase III efficacy clinical study results of Sanofi’s Dengue vaccine candidate published Study successfully met primary objective and confirms high efficacy against severe dengue and hospitalisation
